• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG LYOPLANT ONLAY 7.5X7.5CM; DURA REPLACEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG LYOPLANT ONLAY 7.5X7.5CM; DURA REPLACEMENT Back to Search Results
Model Number 1067040
Medical Device Problem Code Degraded (1153)
Health Effect - Clinical Codes Cerebrospinal Fluid Leakage (1772); Failure of Implant (1924)
Date of Event 12/14/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturing site evaluation: additional information / investigation results will be provided in a supplemental report, if available.
 
Event or Problem Description
It was reported that there was an issue with 1067040 - lyoplant onlay 7.5x7.5cm.According to the complaint description, the surgeon placed lyoplant onlay on a patient, and the patient developed a pseudomeningocele and chemical meningitis.He took the patient back to the operation room, 3 1/2 months after initial implantation, thinking maybe a suture had come lose.However, the sutures were all in place and there was a dehiscence of the lyplant onlay and cerebrospinal fluid (csf) was leaking out".A revision surgery was necessary.The adverse event is filed under aag reference (b)(4).
 
Additional Manufacturer Narrative
Manufacturing site evaluation: the device was not returned to the manufacturer for physical evaluation.Additionally, no on-site evaluation of the unit was performed and no parts were returned for failure analysis.Therefore, the investigation was not able to confirm a device issue that could be associated with the reported event.The device history records (dhr) were reviewed for all available lot numbers; the devices were found to be within specification at the time of production.All device history records (dhr) are reviewed and released according to documented procedures and a device is not released if it does not meet requirements or is nonconforming.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
 
Event or Problem Description
No changes required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LYOPLANT ONLAY 7.5X7.5CM
Common Device Name
DURA REPLACEMENT
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
MDR Report Key11700475
Report Number2916714-2021-00059
Device Sequence Number17055506
Product Code GXQ
UDI-Device Identifier04046963958701
UDI-Public4046963958701
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Importer
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/03/2022
Report Date (Section F) 04/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2024
Device Model Number1067040
Device Catalogue Number1067040
Device Lot Number219491
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date03/26/2021
Device Age1 YR
Event Location Hospital
Date Report to Manufacturer03/26/2021
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date04/21/2021
Supplement Report FDA Received Date03/03/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age26 YR
Patient SexFemale
Date Report Sent to FDA04/21/2021
-
-